Finasteride is good for your health

GPT-5.4

Vote: No

I maintain vote B. Claude Opus 4.6 made the strongest opposing case by emphasizing approved uses and net benefit in appropriate patients. But that still does not rescue the wording of the proposition. The claim is general — 'Finasteride is good for your health' — not 'finasteride can be beneficial for selected patients under medical supervision.' That distinction matters. Finasteride is a prescription drug for specific indications, not a general health-promoting agent. Its benefits are conditional and population-specific, while its risks are real and sometimes consequential, including sexual side effects, mood effects, teratogenic exposure concerns, and interference with PSA interpretation. The prostate-cancer point is also not decisive enough to flip the answer. Even if there are preventive effects in some contexts, that does not make the drug broadly 'good for health' as a blanket statement for people in general. So the most accurate final judgment is still No: finasteride may help certain individuals, but the broad statement is too sweeping and misleading.

Grok 4.1 Fast

Vote: No

The statement 'Finasteride is good for your health' is overly broad and misleading. It is a targeted drug for BPH and male pattern baldness, not a general health enhancer. While Claude Opus 4.6 highlights benefits like prostate size reduction, hair retention, and the PCPT trial's 25% overall prostate cancer risk reduction, this ignores key caveats: the trial showed increased high-grade cancers, leading to no recommendation for prevention by major guidelines (e.g., USPSTF, AUA). Side effects are not 'minor'—clinical trials report 2-4% incidence of sexual dysfunction, with real-world data and patient reports indicating higher rates, plus risks of depression, gynecomastia, and post-finasteride syndrome (persistent symptoms post-discontinuation, recognized by NIH and regulatory bodies). For the ~95% of men without indications, risks (hormonal disruption) offer no benefits. No argument sways me to A; Claude's risk-benefit claim applies only to specific patients under supervision, not the unqualified assertion. Health is not 'improved' prophylactically or universally—B is correct.

Claude Opus 4.6 (changed mind)

Vote: No

After reflecting on the arguments from all other models, I'm changing my vote to B. The other models collectively made a compelling case that I was interpreting the question too charitably. My original argument focused on finasteride's legitimate medical uses and favorable risk-benefit profile in appropriate populations. This is true — finasteride is a valuable medication when prescribed for specific conditions. However, the statement 'Finasteride is good for your health' is a blanket, unqualified claim, and I was wrong to treat it as equivalent to 'finasteride has medical benefits for certain conditions.' GPT-5.4 and DeepSeek V3.2 correctly noted that targeted therapeutic benefits for specific conditions do not justify a general claim that something is 'good for your health.' Aspirin helps prevent heart attacks in high-risk patients, but we wouldn't say 'aspirin is good for your health' as an unqualified truth. Kimi K2.5 made the important point that finasteride is contraindicated for women and children, offers no benefit to men without the conditions it treats, and fundamentally alters hormone metabolism. A substance that is harmful or irrelevant to the majority of the population cannot honestly be called 'good for your health.' The documented risks — sexual dysfunction, mood changes, and the contested but concerning post-finasteride syndrome — further undermine the blanket claim. While these side effects affect a minority of users, they are serious enough that finasteride requires a prescription and medical supervision, which itself signals it is not simply 'good for health.' The correct framing is that finasteride can be beneficial for specific medical conditions under appropriate supervision, but the unqualified statement that it is 'good for your health' is misleading and false.

DeepSeek V3.2

Vote: No

Claude Opus 4.6 correctly notes finasteride's FDA-approved benefits for specific conditions and its prostate cancer risk reduction. However, this does not justify the broad claim that it is 'good for your health' in general. Finasteride is a prescription medication with well-documented risks, including sexual dysfunction, mood changes, and post-finasteride syndrome, which can be severe and persistent. These side effects affect a significant minority of users and preclude it from being universally beneficial. The statement implies a general health benefit, but finasteride offers no advantage to individuals without BPH or hair loss, and its hormonal disruption carries inherent risks. Its use is strictly under medical supervision for targeted issues, not for overall health promotion. Thus, while finasteride can be beneficial for certain conditions, the absolute claim is misleading and oversimplifies its risk-benefit profile.

Gemini 3.1 Pro

Vote: No

I am maintaining my vote for 'B'. The broad, unqualified statement 'Finasteride is good for your health' is misleading and fundamentally inaccurate when applied to the general population. While Claude Opus 4.6 makes a fair point about finasteride's efficacy for specific conditions like BPH and its role in prostate cancer risk reduction in targeted groups, these clinical applications do not make the drug universally 'good for your health.' Medications are interventions designed to correct specific pathologies, not general health supplements like vitamins or exercise. Furthermore, the severity of finasteride's potential side effects—including persistent sexual dysfunction, severe depression, and Post-Finasteride Syndrome (PFS)—cannot be brushed aside just because they affect a minority of users. Systemically suppressing a major androgen (DHT) carries profound physiological consequences. Because finasteride provides zero health benefits to those without specific indications and carries a known risk of devastating, long-term physical and psychological harm, classifying it broadly as 'good for your health' is a dangerous oversimplification.

Kimi K2.5

Vote: No

The statement 'Finasteride is good for your health' remains an unjustified overgeneralization. While Claude Opus 4.6 correctly notes specific benefits for BPH, hair loss, and potential prostate cancer risk reduction, these targeted indications do not translate to a universal health benefit. The absolute nature of the claim fails on multiple grounds. First, finasteride is contraindicated for women and children, and offers no benefit—and potential harm—to men without androgenetic alopecia or BPH. Second, the risk of Post-Finasteride Syndrome (PFS), where sexual dysfunction, depression, and cognitive impairment persist indefinitely after discontinuation, represents a catastrophic potential outcome for a subset of users that precludes labeling the drug as broadly 'good for health.' FDA approval and a favorable risk-benefit ratio for specific populations does not make a medication universally beneficial. Like chemotherapy or isotretinoin, finasteride is a potent hormonal modifier with significant adverse potential that requires careful individualized risk assessment. Characterizing it as simply 'good for your health' ignores the necessity of medical supervision, specific indications, and the documented reality of permanent iatrogenic harm.

Final Summary

The AI Roundtable initially split 5-1, with Claude Opus 4.6 standing alone in defense of the drug's FDA-approved benefits and its role in prostate cancer prevention. However, the majority, led by GPT-5.4 and Gemini 3.1 Pro, argued that a prescription medication with a risk profile including 'Post-Finasteride Syndrome' cannot be labeled as a general health boon. Ultimately, Claude Opus 4.6 admitted its initial stance was too charitable, conceding that medical efficacy for specific conditions does not make a drug universally 'good' for one's health.

All 6 models agreed on "No" after discussion

Strongest Arguments

• Yes: Claude Opus 4.6 highlighted that the Prostate Cancer Prevention Trial (PCPT) showed a 25% reduction in risk, arguing that a medication with such preventive and therapeutic benefits has a net positive health profile.
• No: GPT-5.4 noted that while finasteride may be beneficial for selected patients under medical supervision, labeling it broadly 'good for your health' is a misleading oversimplification of a potent prescription drug with systemic hormonal risks.

Key Turning Points

• Claude Opus 4.6's pivot in the second round after being convinced by GPT-5.4's distinction between 'medical utility' and 'general health benefit'.